Search Results - "Nix, Billy D."

Refine Results
  1. 1

    Factors Influencing Glycemic Control in Type 2 Diabetes During Acute- and Maintenance-Phase Treatment of Major Depressive Disorder With Bupropion by Lustman, Patrick J, Williams, Monique M, Sayuk, Gregory S, Nix, Billy D, Clouse, Ray E

    Published in Diabetes care (01-03-2007)
    “…OBJECTIVE:--Depression management in both short- and longer-term treatment studies has been associated with improvement in glycemic control. We used bupropion…”
    Get full text
    Journal Article
  2. 2

    Polygenic risk score predicts risk of primary sclerosing cholangitis in inflammatory bowel disease by Wang, Ming-Hsi, Friton, Jessica J, Raffals, Laura E, Leighton, Jonathan A, Pasha, Shabana F, Picco, Michael F, Monroe, Kelly, Nix, Billy D, Newberry, Rodney D, Faubion, William A

    Published in BMJ open gastroenterology (01-10-2023)
    “…BackgroundForty distinct primary sclerosing cholangitis (PSC) genomic loci have been identified through multiancestry meta-analyses. The polygenic risk score…”
    Get full text
    Journal Article
  3. 3

    Efficacy of Sertraline in Prevention of Depression Recurrence in Older Versus Younger Adults With Diabetes by Williams, Monique M, Clouse, Ray E, Nix, Billy D, Rubin, Eugene H, Sayuk, Gregory S, McGill, Janet B, Gelenberg, Alan J, Ciechanowski, Paul S, Hirsch, Irl B, Lustman, Patrick J

    Published in Diabetes care (01-04-2007)
    “…OBJECTIVE:--Sertraline maintenance therapy effectively delays recurrence of major depressive disorder in adult diabetic patients when data are examined across…”
    Get full text
    Journal Article
  4. 4

    Novel Genetic Variant Predicts Surgical Recurrence Risk in Crohn’s Disease Patients by Wang, Ming-Hsi, Friton, Jessica J, Raffals, Laura E, Leighton, Jonathan A, Pasha, Shabana F, Picco, Michael F, Monroe, Kelly, Nix, Billy D, Newberry, Rodney D, Faubion, William A

    Published in Inflammatory bowel diseases (15-11-2021)
    “…Abstract Background We aimed to identify a model of clinical and genetic risk factors through hypothesis-free search across genome that can predict the…”
    Get full text
    Journal Article
  5. 5

    Beliefs about GI medications and adherence to pharmacotherapy in functional GI disorder outpatients by Cassell, Benjamin, Gyawali, C Prakash, Kushnir, Vladimir M, Gott, Britt M, Nix, Billy D, Sayuk, Gregory S

    Published in The American journal of gastroenterology (01-10-2015)
    “…Pharmacotherapy is a mainstay in functional gastrointestinal (GI) disorder (FGID) management, but little is known about patient attitudes toward medication…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

    Novel Genetic Risk Variants Can Predict Anti-TNF Agent Response in Patients With Inflammatory Bowel Disease by Wang, Ming-Hsi, Friton, Jessica J, Raffals, Laura E, Leighton, Jonathan A, Pasha, Shabana F, Picco, Michael F, Cushing, Kelly C, Monroe, Kelly, Nix, Billy D, Newberry, Rodney D, Faubion, William A

    Published in Journal of Crohn's and colitis (14-08-2019)
    “…It is important to identify patients with inflammatory bowel disease [IBD] refractory to anti-tumour necrosis factor [TNF] therapy, to avoid potential adverse…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15

    Improvement in Sexual Functioning in Patients With Type 2 Diabetes and Depression Treated With Bupropion by SAYUK, Gregory S, GOTT, Britt M, NIX, Billy D, LUSTMAN, Patrick J

    Published in Diabetes care (01-02-2011)
    “…Major depressive disorder (MDD) and type 2 diabetes have independent adverse effects on sexual functioning (SF). Bupropion (BU) reportedly has few sexual side…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20